Document Detail


Vasodilators in acute heart failure.
MedLine Citation:
PMID:  17447137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Most patients with acute heart failure present with increased left ventricular filling pressure and high or normal blood pressure; only a minority present with cardiogenic shock. In this context, therapy with vasodilators in the acute setting can improve both hemodynamics and symptoms. Vasodilators are usually given in conjunction with diuretics, although much of the acute effect of loop diuretics may be due to venodilation. Currently available agents include nitroglycerin, nitroprusside, and nesiritide. Nitroglycerin relieves pulmonary congestion primarily through direct venodilation, but may dilate coronary arteries and increase collateral blood flow at higher doses, an effect desirable in patients with ischemia. Tachyphylaxis may develop, necessitating incremental dosing. The major adverse effects of nitrates are hypotension and headache. Nitroprusside is a balanced arterial and venous vasodilator with a very short half-life, facilitating rapid titration. Afterload reduction lowers blood pressure and can increase stroke volume. The major complications of nitroprusside therapy are hypotension, and toxicity from accumulation of cyanide or thiocyanate, usually in patients with renal insufficiency treated for more than 24 h. Nesiritide, a recombinant form of human B-type natriuretic peptide (BNP), is a venous and arterial vasodilator that may also potentiate the effect of concomitant diuretics. Hypotension is the most common side effect. In addition, meta-analyses have suggested that nesiritide may worsen renal function and decrease survival at 30 days compared to conventional therapies. Resolution of these concerns awaits completion of appropriately powered prospective clinical trials. Angiotensin-converting enzyme (ACE) inhibitors have vasodilatory effects, but intravenous infusion of enalapril within 24 h of ischemic chest pain is not recommended. Oral ACE inhibition may be used to reduce afterload in other settings if blood pressure permits. Use of calcium antagonists in acute heart failure is not recommended.
Authors:
Steven M Hollenberg
Related Documents :
20169597 - Volume 77a, number 3, march 2010 cover image.
6097377 - Angiotensin converting enzyme during acute and chronic enalapril therapy in essential h...
23579517 - A prospective randomized study of systemic inflammation and immune response after lapar...
1735587 - Effect of bradykinin on isolated mesenteric arteries of the rat.
23295877 - Effects of an exercise program on blood pressure in patients with treated hypertension ...
497527 - The cardiovascular pharmacology of 7-propyl-theo-phylline-dopamine (d4975); comparison ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Heart failure reviews     Volume:  12     ISSN:  1382-4147     ISO Abbreviation:  Heart Fail Rev     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-06-13     Completed Date:  2007-08-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9612481     Medline TA:  Heart Fail Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  143-7     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Disease, Cooper University Hospital, One Cooper Plaza, 366 Dorrance, Camden, NJ 08103, USA. Hollenberg-Steven@cooperhealth.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Clinical Trials as Topic
Diuretics / therapeutic use*
Drug Therapy, Combination
Heart Failure / drug therapy*
Humans
Natriuretic Peptide, Brain / therapeutic use
Nitroglycerin / therapeutic use
Nitroprusside / therapeutic use
Treatment Outcome
Vasodilator Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Diuretics; 0/Vasodilator Agents; 114471-18-0/Natriuretic Peptide, Brain; 15078-28-1/Nitroprusside; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Therapeutic and diagnostic role of electrical devices in acute heart failure.
Next Document:  Diuretics for the treatment of acute decompensated heart failure.